Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Aslan Pharmaceuticals

www.aslanpharma.com

10A Bukit Pasoh Road
Singapore
089824
Singapore

+65 6222 4235

Activities

Pharmaceutical

Related Content

Aslan Pharmaceuticals makes appointments to scientific board
Aslan Pharmaceuticals makes appointments to scientific board
ASLAN and BioGenetics sign second commercialisation agreement
ASLAN and BioGenetics sign second commercialisation agreement
Therapeutics: anticancer agent: varlitinib
Therapeutics: anticancer agent: varlitinib
Aslan cuts costs by 50% to compensate for failed drug trial
Aslan cuts costs by 50% to compensate for failed drug trial
Aslan announces shortened timeline to commercialisation for varlitinib
Aslan announces shortened timeline to commercialisation for varlitinib
Aslan Pharmaceuticals receives IND approval by Singapore’s Health Sciences Authority
Aslan Pharmaceuticals receives IND approval by Singapore’s Health Sciences Authority
Aslan Pharmaceuticals announces new research collaboration
Aslan Pharmaceuticals announces new research collaboration
ASLAN Pharmaceuticals CEO Dr Carl Firth appointed to IAC singapore
ASLAN Pharmaceuticals CEO Dr Carl Firth appointed to IAC singapore
ASLAN Pharmaceuticals commences first day of trading on Taipei Exchange
ASLAN Pharmaceuticals commences first day of trading on Taipei Exchange
ASLAN Pharmaceuticals moves Taiwan office
ASLAN Pharmaceuticals moves Taiwan office
Aslan wins Biosingapore Innovative Biomedical Company award
Aslan wins Biosingapore Innovative Biomedical Company award
Aslan pharmaceuticals receives approval to list on Taipei exchange
Aslan pharmaceuticals receives approval to list on Taipei exchange
JHL Biotech and ASLAN to partner on manufacturing services for ASLAN004
JHL Biotech and ASLAN to partner on manufacturing services for ASLAN004
Bristol-Myers Squibb regains rights to Aslan cancer drug candidate in Asia
Bristol-Myers Squibb regains rights to Aslan cancer drug candidate in Asia
Aslan Pharmaceuticals raises $23m in pre-IPO financing round
Aslan Pharmaceuticals raises $23m in pre-IPO financing round
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company